Published on in Vol 6, No 3 (2020): Jul-Sep
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/19538, first published
.
![Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir](https://asset.jmir.pub/assets/420f451e2b020c5872ad7a974a43f8c7.png 480w,https://asset.jmir.pub/assets/420f451e2b020c5872ad7a974a43f8c7.png 960w,https://asset.jmir.pub/assets/420f451e2b020c5872ad7a974a43f8c7.png 1920w,https://asset.jmir.pub/assets/420f451e2b020c5872ad7a974a43f8c7.png 2500w)
Journals
- Lin H. Informative Censoring—A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data. Life 2023;13(1):210 View
- Peng L, Gao L, Wu X, Fan Y, Liu M, Chen J, Song J, Kong J, Dong Y, Li B, Liu A, Bao F. Lung Organoids as Model to Study SARS-CoV-2 Infection. Cells 2022;11(17):2758 View
- Govindarajulu U. COVID-19 Research and p -Values. CHANCE 2023;36(3):35 View